- Broad Areas of Research
- Research Themes
- Ask A Biologist
- Recent Publications
-
- Miller Lab: Role of Vinculin in Tricellular Junctions
- Jakob Lab: Embryonic Stem Cell Fate
- Wierzbicki Lab: Membrane association of active genes organizes the chloroplast nucleoid structure
- Shan Lab: Dual phosphorylation of DGK5-mediated PA burst regulates ROS in plant immunity
- Simmons Lab: Bacillus subtilis encodes a discrete flap endonuclease that cleaves RNA-DNA hybrids
- DeSantis/Nandakumar Labs: KASH5 protein
- Cadigan Lab: SOX9 and TCF transcription factors associate to mediate Wnt/β-catenin target gene activation in colorectal cancer
Jakob Lab: Embryonic Stem Cell Fate
Redox heterogeneity in mouse embryonic stem cells individualizes cell fate decisions
Agnes Ulfig, Ursula Jakob
Pluripotent embryonic stem cells (ESCs) can develop into any cell type in the body. Yet, the regulatory mechanisms that govern cell fate decisions during embryogenesis remain largely unknown. We now demonstrate that mouse ESCs (mESCs) display large natural variations in mitochondrial reactive oxygen species (mitoROS) levels that individualize their nuclear redox state, H3K4me3 landscape, and cell fate. While mESCs with high mitoROS levels (mitoROSHIGH) differentiate toward mesendoderm and form the primitive streak during gastrulation, mESCs, which generate less ROS, choose the alternative neuroectodermal fate. Temporal studies demonstrated that mesendodermal (ME) specification of mitoROSHIGH mESCs is mediated by a Nrf2-controlled switch in the nuclear redox state, triggered by the accumulation of redox-sensitive H3K4me3 marks, and executed by a hitherto unknown ROS-dependent activation process of the Wnt signaling pathway. In summary, our study explains how ESC heterogeneity is generated and used by individual cells to decide between distinct cellular fates.